BG

Kriya Therapeutics

PVT · PVT·Research Triangle Park, NC·Private·Phase 1

Clinical-stage gene therapy company developing one-time, focally delivered AAV-based treatments for chronic diseases affecting large patient populations. Backed by over $1.2B in funding, with programs spanning ophthalmology, metabolic disease, and neurology.

Decks (1)

TitleOccasionDateSlidesSource
Kriya Therapeutics websiteWebsiteMay 6, 20264PDF